Status:
RECRUITING
Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Bone Angioma
Eligibility:
All Genders
18+ years
Brief Summary
The investigators aimed to evaluate efficacy and safety of a non-surgical protocol treatment combining transarterial embolization and percutaneous radiopaque gelled ethanol (RGE) sclerotherapy in a fi...
Eligibility Criteria
Inclusion
- Every patients treated by gelled alcohol sclerotherapy for aggressive angiomas, in the University Hospital of Saint-Etienne.
Exclusion
- Patients no treated by gelled alcohol sclerotherapy.
Key Trial Info
Start Date :
June 25 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT06607731
Start Date
June 25 2024
End Date
December 1 2024
Last Update
October 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Saint-Etienne
Saint-Priest-en-Jarez, France, 42270